ZA200703603B - Macrolones - amino substituted quinolones - Google Patents

Macrolones - amino substituted quinolones Download PDF

Info

Publication number
ZA200703603B
ZA200703603B ZA200703603A ZA200703603A ZA200703603B ZA 200703603 B ZA200703603 B ZA 200703603B ZA 200703603 A ZA200703603 A ZA 200703603A ZA 200703603 A ZA200703603 A ZA 200703603A ZA 200703603 B ZA200703603 B ZA 200703603B
Authority
ZA
South Africa
Prior art keywords
dihydro
oxo
carboxy
dimethylamino
erythromycin
Prior art date
Application number
ZA200703603A
Other languages
English (en)
Inventor
Best Desmond John
Elder John Stephen
Fajdetic Andrea
Forrest Andrew Keith
Sheppard Robert John
Original Assignee
Glaxo Group Ltd
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Glaxosmithkline Zagreb filed Critical Glaxo Group Ltd
Publication of ZA200703603B publication Critical patent/ZA200703603B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200703603A 2004-11-11 2007-05-04 Macrolones - amino substituted quinolones ZA200703603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424959A GB0424959D0 (en) 2004-11-11 2004-11-11 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200703603B true ZA200703603B (en) 2008-07-30

Family

ID=33523587

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703603A ZA200703603B (en) 2004-11-11 2007-05-04 Macrolones - amino substituted quinolones

Country Status (19)

Country Link
US (2) US7718621B2 (enExample)
EP (1) EP1824870A1 (enExample)
JP (1) JP2008519788A (enExample)
KR (1) KR20070085919A (enExample)
CN (1) CN101098881A (enExample)
AR (1) AR053311A1 (enExample)
AU (1) AU2005303961A1 (enExample)
BR (1) BRPI0517792A (enExample)
CA (1) CA2587413A1 (enExample)
GB (1) GB0424959D0 (enExample)
IL (1) IL182978A0 (enExample)
MA (1) MA29213B1 (enExample)
MX (1) MX2007005776A (enExample)
NO (1) NO20072939L (enExample)
PE (1) PE20061137A1 (enExample)
RU (1) RU2007121581A (enExample)
TW (1) TW200630378A (enExample)
WO (1) WO2006050942A1 (enExample)
ZA (1) ZA200703603B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
JP2008540504A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用な4’’アミノ結合マクロライド
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
AU2008298545B2 (en) 2007-09-14 2013-12-12 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ,インコーポレイテッド マラリア、結核、及びmac病の治療方法
CA2799937A1 (en) * 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法
CN106589023A (zh) * 2016-11-22 2017-04-26 宜昌东阳光药业股份有限公司 一种罗红霉素杂质及其合成方法
WO2018178041A1 (en) 2017-03-30 2018-10-04 F. Hoffmann-La Roche Ag Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
US20080269146A1 (en) 2008-10-30
CA2587413A1 (en) 2006-05-18
PE20061137A1 (es) 2006-12-13
KR20070085919A (ko) 2007-08-27
MA29213B1 (fr) 2008-02-01
AR053311A1 (es) 2007-05-02
RU2007121581A (ru) 2008-12-20
NO20072939L (no) 2007-08-08
GB0424959D0 (en) 2004-12-15
EP1824870A1 (en) 2007-08-29
CN101098881A (zh) 2008-01-02
BRPI0517792A (pt) 2008-10-21
MX2007005776A (es) 2007-07-16
WO2006050942A1 (en) 2006-05-18
US20080090773A1 (en) 2008-04-17
TW200630378A (en) 2006-09-01
AU2005303961A1 (en) 2006-05-18
JP2008519788A (ja) 2008-06-12
IL182978A0 (en) 2007-08-19
US7718621B2 (en) 2010-05-18

Similar Documents

Publication Publication Date Title
ZA200703603B (en) Macrolones - amino substituted quinolones
EP1628989B1 (en) Novel 14 and 15 membered-ring compounds
EP1756135B1 (en) Ester linked macrolides useful for the treatment of microbial infections
US20090111760A1 (en) Macrolone compounds
EP1628988B1 (en) Novel 14 and 15 membered-ring compounds
CA2525449A1 (en) Macrolides substituded at the 4"-position
EP1628990B1 (en) Novel 14 and 15 membered ring compounds
WO2004101589A1 (en) Novel 14 and 15 membered-ring compounds
US20090062218A1 (en) Macrolone compounds
EP1633765B1 (en) Novel 14 and 15 membered-ring compounds
US20080096829A1 (en) Macrolone Compounds
WO2004101584A1 (en) Macrolides substituted at the 3-position having antimicrobial activity
WO2006120545A1 (en) 4' amino linked macrolides useful for the treatment of microbial infections
EP1756134A1 (en) Carbamate linked macrolides useful for the treatment of microbial infections
WO2007054295A1 (en) New 4*-substituted erythromycin derivative